HomeNewsBusinessAs Covid pounds aviation, a once glamorous career option loses sheen

As Covid pounds aviation, a once glamorous career option loses sheen

Airlines are bleeding and losses are mounting, once a promising sector, India’s aviation industry is struggling. Layoffs and salary cuts are the order of the day. Is the aviation sector still the place to be? Read on

June 20, 2021 / 11:56 IST
Story continues below Advertisement
Illustration: Suneesh Kalarickal
Illustration: Suneesh Kalarickal

Layoffs, salary cuts and mounting losses—the coronavirus outbreak has dealt a body blow to an already struggling aviation industry as curbs on the movement of people to contain the spread of the infection has hit travel.

In the financial year 2021, domestic traffic slipped to a 10-year low of 53.4 million passengers, rating agency ICRA said in a report. IndiGo, the country’s biggest airline, reported a net loss of Rs 1,147.2 crore in the quarter ending March 2021. The fifth straight quarter of loss for the airline that has a domestic market share of more than 50 percent. The low-cost carrier has reported a net loss of Rs 870.8 crore in March 2020.

Story continues below Advertisement

The second coronavirus wave that sent daily infections and deaths zooming in the country hobbled the industry just when things were beginning to look up. In May 2021, domestic passenger traffic stood at 19-20 lakh compared to 57.3 lakh in the previous month, a decline of 65-67 percent, ICRA said.

India stopped commercial international flights in March 2020 and the ban has been extended to June 30. Even domestically, airlines are flying with restrictions, including passengers they can carry.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show